amikacin has been researched along with Bacterial Infections, Gram-Positive in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (43.75) | 18.2507 |
| 2000's | 13 (40.63) | 29.6817 |
| 2010's | 5 (15.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Alidjinou, EK; Bonnet, I; Canis, F; Cattoen, C; Dewulf, G; Mazars, E | 1 |
| Damasceno, EF; Damasceno, NP; Horowitz, SA | 1 |
| Fili, S; Hayvazov, S; Kohlhaas, M; Kontopoulou, K; Schilde, T | 1 |
| Chen, KJ; Sun, CC; Yang, KJ; Yeung, L | 1 |
| Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C | 1 |
| Asseray, N; Bugnon, D; Caillon, J; Dubé, L; Jacqueline, C; Potel, G | 1 |
| Hewer, SL | 1 |
| Matoba, AY | 1 |
| Arlet-Suau, E; Astudillo, L; Lefevre, JC; Massip, P; Porte, L; Sailler, L | 1 |
| Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC | 1 |
| Bagattini, M; Crispino, M; Di Popolo, A; Florio, A; Fortunato, R; Triassi, M; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| Bujdákova, H; Drahovská, H; Filipová, M; Hanzen, J; Lisková, A | 1 |
| Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Cogoluenhes, V; Confesson, MA; Courpron, P; Druguet, M; Grillot, M; Jelliffe, RW; Maire, PH; Pivot, C | 1 |
| Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
| Carbon, C | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| Donazzan, M; Ferri, F; Rose, C; Tellion, C | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
| Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G | 1 |
| Chow, JW; Clewell, DB; Donabedian, SM; Sahm, DF; Zervos, MJ | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Baril, L; Boiron, P; Bricaire, F; Caumes, E; Ely, SO; Favre, E; Jamet, P; Manceron, V | 1 |
| Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG | 1 |
| Conrad, SA; King, JW; Todd, JR; White, MC | 1 |
2 review(s) available for amikacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Inhaled antibiotics in cystic fibrosis: what's new?
Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Preschool; Ciprofloxacin; Clinical Trials, Phase III as Topic; Cystic Fibrosis; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate; Tobramycin; Treatment Outcome | 2012 |
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy | 2005 |
8 trial(s) available for amikacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome | 2009 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Antineoplastic Agents; Ceftazidime; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Superinfection | 1996 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2000 |
22 other study(ies) available for amikacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
[Gardnerella vaginalis bacteremia in a male patient].
Topics: Adenocarcinoma; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Chemotherapy, Adjuvant; Colostomy; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Middle Aged; Peritoneal Neoplasms; Sigmoid Neoplasms | 2013 |
Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.
Topics: Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Leuconostoc; Male; Postoperative Complications; Ranibizumab; Vascular Endothelial Growth Factor A; Vitreous Body; Wet Macular Degeneration | 2016 |
[Low grade endophthalmitis caused by P. acnes : Case report].
Topics: Aged, 80 and over; Amikacin; Combined Modality Therapy; Diagnosis, Differential; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lenses, Intraocular; Postoperative Complications; Propionibacterium acnes; Vancomycin; Vitrectomy | 2016 |
Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Endophthalmitis; Enterobacter; Enterobacteriaceae Infections; Enterococcus; Eye Injuries, Penetrating; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin; Wound Infection | 2009 |
The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Netilmicin; Rabbits; Time Factors; Tobramycin | 2012 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Spondylodiscitis due to Aerococcus urinae: a first report.
Topics: Aged; Amikacin; Amoxicillin; Clindamycin; Discitis; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Lumbar Vertebrae; Microbial Sensitivity Tests; Rare Diseases; Risk Assessment; Streptococcaceae; Treatment Outcome | 2003 |
Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chromosomes, Bacterial; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gene Transfer Techniques; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Gentamicins; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 2005 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Occurrence of aminoglycoside-modifying-enzyme genes aac(6')-aph(2"), aph(3'), ant(4') and ant(6) in clinical isolates of Enterococcus faecalis resistant to high-level of gentamicin and amikacin.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Nucleotidyltransferases; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction | 2006 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
[Adaptive control of therapeutics using amikacin in very old patients: retrospective analysis of efficacy and toxicity].
Topics: Aged; Aged, 80 and over; Amikacin; Creatinine; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Retrospective Studies | 1994 |
[Severe diffuse facial cellulitis].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Cause of Death; Cellulitis; Child; Drug Therapy, Combination; Face; Female; Forecasting; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Neck; Penicillins; Piperacillin; Premedication; Risk Factors; Treatment Outcome | 1997 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin | 1998 |
In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
Topics: Amikacin; Ampicillin; Animals; Dibekacin; DNA Primers; DNA Probes; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Synergism; Electrophoresis, Agar Gel; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Netilmicin; Penicillins; Polymerase Chain Reaction | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Refractory craniofacial actinomycetoma due to Streptomyces somaliensis that required salvage therapy with amikacin and imipenem.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Face; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Magnetic Resonance Imaging; Mycetoma; Salvage Therapy; Skull; Streptomyces; Thienamycins | 1999 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome | 1992 |
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside.
Topics: Amikacin; Bacteremia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Louisiana; Prospective Studies; Tobramycin | 1992 |